* Download comes with a free subscription to our newsletter. You can unsubscribe any time. You will not get duplicate emails if you download more than one report.

  1. 3
  1. You must first login , or register before you can comment.

    Markdown formatting available
     

  2. 3

    Great story, @KickAssBrockSamson.

    @rhonda… The article gets a bit more interesting down past the apple watch part. (Search the page for “hypothesis generation source.”)

    FTA:

    Ultimately, clinical studies will be necessary to establish links between treatments and outcomes, and Hadeishi sees Curious’ software in part as a “hypothesis generation source.” In the past, clinicians could come up with broad theories about what works simply by observing their patients, but in the future doctors need to develop treatments tailored to subsets of patients based on their unique physiologies, so patterns are harder to detect. Tools like Curious’ software could help scientists develop testable ideas.

    1. 1

      @kickAssBrockSamson This is really awesome! I’m also really excited about how Theranos can use analytical methods to measure lipids, hormones, and even vitamin D from a finger-prick of blood. If it was totally consumer-based would be even better. If I want to measure my vitamin D levels to know how much I’m getting then why should I need a doctor prescribe the test…

    2. 1

      I just hope the FDA does not slow down the progress the Bio Tech industry is making. The future looks bright :D

      1. 2

        @KickAssBrockSamson, @rhonda, Theranos' Board is absolutely stacked and unlikely to be slowed by the FDA. http://www.theranos.com/our-company

        1. 1

          The transparency of their pricing structure is awesome, but I’m a bit curious what the consumer experience will be like. Will I be able to walk into a walgreens and order up my own test with one of their machines… or will I need to make a more formal appointment with a professional in order to get what I want?

          My personal favorite? The availability of both.

          1. 2

            They’ll have both for sure. As amazing as it sounds right now it’s my opinion that Theranos will NOT be the revolutionary boon to personalized medicine. Internally they are going to have the absolute best information and technology, bar-none, but publicly I believe they will only release marginally improved testing.

            1. 1

              Really? That’s sort of interesting. If they do have both, I’d expect that would be a huge boon… Why do you think otherwise?

              1. 2

                Because of the background of their sponsors, board, and partners AND because of the implications of that technology being fully public. It is just far too valuable to keep that technology locked and proprietary. Also the united states has a history of prosecuting anyone in health that is too progressive. 23AndMe, Royal Raymond Rife, etc..

        2. 1

          I agree!